Join the community
Most Read
1. How can Asia-Pacific prove medical research is worth the money? 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. China's healthcare sector set for global breakout 4. China healthcare lags Hong Kong and global markets in 2026 5. Healthway Medical expands with Bridgepoint Health buyResource Center
Partner Events
Event News
Medical Taiwan 2026 closes with $168.7m in business opportunities
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential